Compounds > simendan
Page last updated: 2024-08-24

simendan and Necrosis

simendan has been researched along with Necrosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Akyol, ME; Aycan, A; Ergur, B; Gonullu, E; Kume, T; Kuyumcu, F; Oksuz, E; Tas, A1
Adams, V; Barthel, P; Linke, A; Poitz, DM; Schauer, A; Weinbrenner, C1
Aliabadi, A; Buchberger, E; de Martin, R; Demyanets, S; Gröger, M; Hofer-Warbinek, R; Huber, K; Kastl, SP; Kaun, C; Krychtiuk, KA; Maurer, G; Pisoni, J; Rauscher, S; Speidl, WS; Watzke, L; Wojta, J; Zuckermann, A1
Caimmi, PP; Cattaneo, M; Grossini, E; Mary, DA; Molinari, C; Platini, F; Tessitore, L; Uberti, F; Vacca, G; Valente, G1
Aksun, M; Bahriye Lafci, B; Gurbuz, A; Ortac, R; Ozbek, C; Tulukoglu, E; Yakut, N; Yasa, H1

Other Studies

5 other study(ies) available for simendan and Necrosis

ArticleYear
A New Approach in the Treatment of Traumatic Brain Injury: The Effects of Levosimendan on Necrosis, Apoptosis, and Oxidative Stress.
    World neurosurgery, 2022, Volume: 168

    Topics: Animals; Apoptosis; Brain Injuries, Traumatic; Caspase 3; Catalase; Female; Malondialdehyde; Necrosis; Oxidative Stress; Rats; Rats, Wistar; Simendan; Superoxide Dismutase

2022
Pharmacological Pre- and Postconditioning With Levosimendan Protect H9c2 Cardiomyoblasts From Anoxia/Reoxygenation-induced Cell Death via PI3K/Akt Signaling.
    Journal of cardiovascular pharmacology, 2021, 03-01, Volume: 77, Issue:3

    Topics: Animals; Apoptosis; Autophagy; Cardiovascular Agents; Cell Hypoxia; Cell Line; Mitochondria, Heart; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocytes, Cardiac; Necrosis; Phosphatidylinositol 3-Kinase; Potassium Channels; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Simendan

2021
Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitro.
    Thrombosis and haemostasis, 2015, Volume: 113, Issue:2

    Topics: Anti-Inflammatory Agents; Cell Adhesion; Cells, Cultured; Decanoic Acids; E-Selectin; Enzyme-Linked Immunosorbent Assay; Heart Failure; Human Umbilical Vein Endothelial Cells; Humans; Hydrazones; Hydroxy Acids; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Interleukin-8; Microcirculation; Microscopy, Fluorescence; Muscle Cells; Myocardial Infarction; Myocytes, Cardiac; Necrosis; Neutrophils; NF-kappa B; Phosphorylation; Pyridazines; Reactive Oxygen Species; Simendan; Vasodilator Agents

2015
Modulation of programmed forms of cell death by intracoronary levosimendan during regional myocardial ischemia in anesthetized pigs.
    Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:1

    Topics: Anesthesia; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; bcl-2-Associated X Protein; Blood Pressure; Cardiotonic Agents; Coronary Circulation; Cytochromes c; Gene Expression; Heart; Heart Rate; Hydrazones; In Situ Nick-End Labeling; Microtubule-Associated Proteins; Myocardial Ischemia; Myocardium; Necrosis; Proto-Oncogene Proteins c-bcl-2; Pyridazines; Simendan; Sus scrofa; Venous Pressure; Ventricular Function, Left

2010
The influence of levosimendan and iloprost on renal ischemia-reperfusion: an experimental study.
    Interactive cardiovascular and thoracic surgery, 2008, Volume: 7, Issue:2

    Topics: Animals; Atrophy; Disease Models, Animal; Female; Hydrazones; Iloprost; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Malondialdehyde; Necrosis; Protective Agents; Pyridazines; Rabbits; Reperfusion Injury; Simendan

2008